One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.

Zibo FengShuofei YangHongfei SangGuanhua XueQihong NiLan ZhangWei ZhangXin FangMeng Ye

Published in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)

DA + DCB appears to be a safe and effective endovascular therapy to treat FPAD in real-world clinical practice, with a promising 1-year patency rate with a low rate of bailout stenting.

Keyphrases

clinical practice
risk factors
antiplatelet therapy
emergency department
acute coronary syndrome
aortic dissection
mesenchymal stem cells
adverse drug